Greece, Facebook Co...
Health Care: Drugs
Capstone Therapeutics Corp (CAPS: OTC)
$0.16 0.00 | 0.00%
05/23/12 - 03:26 PM ET
5.09K / 178.70K
Vol / Avg. Vol:0.16 / 0.16
Open / Prev. Close:0.16 - 0.16
Today's Range:0.17 - 0.40
52 Wk Range:-56.55%
Performance YTD:TheStreet Rating:
Portfolios with CAPS
- Portfolio NameUser Type
- UserDash Rip Rock
- Userlane124 Portfolio 1
- UserUndervalued Biotech's
- Usertruce Portfolio 1
Latest CAPS Headlines from TheStreet
- Insiders Trading ILMN, CAPS and MTG 07.25.11 | 08:07 am
- Capstone Therapeutics To Present At Biotech Showcase 2011 01.06.11 | 04:01 pm
- Capstone Therapeutics Announces Results Of AZX100 Phase 2a Pilot Clinical Trials In Keloid And Surgical Scarring 12.13.10 | 09:12 pm
- Capstone Therapeutics To Host AZX100 Clinical Update Teleconference 12.08.10 | 05:12 pm
- Capstone Therapeutics Announces Third Quarter 2010 Financial Results 11.10.10 | 06:11 am
- Capstone Therapeutics To Host Quarterly Update Conference Call 11.03.10 | 09:11 am
- Capstone Therapeutics To Present At 9th Annual BIO Investor Forum 10.01.10 | 07:10 pm
- Capstone Therapeutics Announces Progress In Clinical Trials Of AZX100 In Keloid Scarring 09.13.10 | 01:09 pm
- Capstone Therapeutics To Present At Rodman & Renshaw 12th Annual Healthcare Conference 09.07.10 | 01:09 pm
- Capstone Therapeutics Announces Second Quarter 2010 Financial Results 08.09.10 | 07:08 am
Press Releases for CAPS
Partner Headlines for CAPS
- Capstone Therapeutics Looking to Capitalize on the Growing Dermal Market - Seeking Alpha 12.10.10 | 04:12 am
